New Vaccine Technology Combats Antibiotic-Resistant Staph Infections
The University of Maryland, Baltimore (UMB) has granted worldwide, exclusive licensing rights for a new vaccine technology to Serenta Biotechnology, a Gaithersburg, Maryland-based startup. The technology, co-owned by UMB and Northern…